Grifols reported EUR5.88B in Equity Capital and Reserves for its fiscal quarter ending in December of 2024.


Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.06M 661K Dec/2024
GlaxoSmithKline GBP 14.35B 197M Jun/2025
Grifols EUR 5.88B 533.83M Dec/2024
Life Technologies USD 74.66M 4.64M Jun/2025